Sun Pharmaceutical Industries Limited (BOM:524715)
India
· Delayed Price · Currency is INR 1,643.05
-26.65 (-1.60%)
At close: Feb 21, 2025
BOM:524715 Statistics
Total Valuation
BOM:524715 has a market cap or net worth of INR 3.94 trillion. The enterprise value is 3.77 trillion.
| Market Cap | 3.94T |
| Enterprise Value | 3.77T |
Important Dates
The last earnings date was Monday, January 27, 2025.
| Earnings Date | Jan 27, 2025 |
| Ex-Dividend Date | Feb 6, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.04B |
Valuation Ratios
The trailing PE ratio is 34.49.
| PE Ratio | 34.49 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 7.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 32.98 |
| EV / Sales | 7.31 |
| EV / EBITDA | 25.54 |
| EV / EBIT | 30.75 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | n/a |
| Interest Coverage | 48.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.20% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 12.00M |
| Profits Per Employee | 2.66M |
| Employee Count | 43,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.78% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +6.78% |
| 50-Day Moving Average | 1,778.18 |
| 200-Day Moving Average | 1,730.70 |
| Relative Strength Index (RSI) | 33.04 |
| Average Volume (20 Days) | 40,659 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524715 had revenue of INR 516.03 billion and earned 114.34 billion in profits. Earnings per share was 47.71.
| Revenue | 516.03B |
| Gross Profit | 403.32B |
| Operating Income | 122.81B |
| Pretax Income | 132.97B |
| Net Income | 114.34B |
| EBITDA | 146.44B |
| EBIT | 122.81B |
| Earnings Per Share (EPS) | 47.71 |
Balance Sheet
The company has 201.22 billion in cash and 25.72 billion in debt, giving a net cash position of 175.50 billion.
| Cash & Cash Equivalents | 201.22B |
| Total Debt | 25.72B |
| Net Cash | 175.50B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 693.80B |
| Book Value Per Share | 288.72 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 78.16%, with operating and profit margins of 23.80% and 22.16%.
| Gross Margin | 78.16% |
| Operating Margin | 23.80% |
| Pretax Margin | 25.77% |
| Profit Margin | 22.16% |
| EBITDA Margin | 28.38% |
| EBIT Margin | 23.80% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 15.50, which amounts to a dividend yield of 0.93%.
| Dividend Per Share | 15.50 |
| Dividend Yield | 0.93% |
| Dividend Growth (YoY) | 24.00% |
| Years of Dividend Growth | 6 |
| Payout Ratio | n/a |
| Buyback Yield | 0.15% |
| Shareholder Yield | 1.08% |
| Earnings Yield | 2.90% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.
| Last Split Date | Jul 29, 2013 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |